Abstract
The British Menopause Society (BMS) has produced this document to provide guidance to BMS members and clinical practitioners to provide information regarding equivalent Hormone Replacement Therapy (HRT) preparations.
The equivalence data included in this practical guide were based on a combination of pharmacokinetics, clinical trials and clinical experience. The dose equivalents included are subject to significant individual variations in absorption and metabolism. HRT practical prescribing including oestradiol starting doses and subsequent dose increments should be guided by symptom control and the patient’s clinical background.
Author: Mr Haitham Hamoda in collaboration with the medical advisory council of the British Menopause Society.
PUBLICATION DATE: MARCH 2022
REVIEW DATE: MARCH 2025